Navigation Links
Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014
Date:7/31/2014

matology and other therapeutic areas. The Company now has a broad portfolio of 12 approved products. Among other products in the U.S., Auxilium markets edex®(alprostadil for injection), an injectable treatment for erectile dysfunction, Osbon ErecAid®, the leading device for aiding erectile dysfunction, STENDRA® (avanafil), an oral erectile dysfunction therapy, Testim®(testosterone gel) for the topical treatment of hypogonadism, an Authorized Generic version of Testim (testosterone gel) with its partner Prasco, LLC, TESTOPEL® (testosterone pellets) a long-acting implantable testosterone replacement therapy, XIAFLEX® (collagenase clostridium histolyticum or CCH) for the treatment of Peyronie's disease and XIAFLEX for the treatment of Dupuytren's contracture. The Company also has programs in Phase 2 clinical development for the treatment of Frozen Shoulder syndrome and cellulite. To learn more, please visit www.Auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995, including statements made with respect to: the Company's intention to announce second quarter 2014 earnings and the timing of such announcement; and other statements regarding matters that are not historical facts, and involve predictions. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''p
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytrens Contracture In Japan
2. Auxilium Pharmaceuticals, Inc. To Present At The J.P. Morgan 32nd Annual Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
4. Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference
5. Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment
6. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
7. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
8. Auxilium Pharmaceuticals, Inc. Raises $50 Million In Additional Financing
9. Auxilium Pharmaceuticals, Inc. To Present At The Stifel Nicolaus Healthcare Conference
10. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
11. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... for the fourth quarter and year ended December ... a pivotal year for Alimera Sciences, most notably ... September for the treatment of diabetic macular edema," ...
(Date:3/4/2015)... , March 4, 2015 Acsis Inc., ... and serialization solutions, announced it will be hosting a ... The live event, "How to Boost Manufacturing Efficiency and ... March 18th at 2:00 PM EDT.  ... Acsis, and John Gordon , Chief Information Officer ...
(Date:3/4/2015)... ROCHESTER, Minn. , March 4, 2015   ... reached an agreement to develop the next generation of ... "We are hoping that this technology will be ... obesity and diabetes," says James Levine, M.D., Ph.D. ... researcher. "They are accurate, inexpensive, and can be integrated ...
Breaking Medicine Technology:Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 14Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... HAYWARD, Calif., Aug. 11, 2011 While media worldwide ... of  food-borne bacterial epidemics, a new USDA study finds ... its toxins--at the center of many of today,s most ... ground-breaking research conducted at the Albany, California, Western Regional ...
... WILLOWICK, Ohio, Aug. 11, 2011 Time is money, and time ... throwing money away. A first-of-its-kind mobile and HTML5 app ... and medical professionals save both time and money. With just a ... to a list of the optimum ultrasound machines based on their ...
Cached Medicine Technology:Scientists at USDA Says CREAGRI HIDROX® Effective Against Staphylococcus aureus Bacteria and Staphylococcus Enterotoxin A 2Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... With the growing influence of movies, television, video games and ... adults, combined with the increasingly frantic lifestyle of modern parents, ... up with what kids are into these days. It seems ... daily basis. , The same is also true for drugs ... to discreetly talk about them, are constantly changing. These tips ...
(Date:3/4/2015)... York, New York (PRWEB) March 04, 2015 ... was reviewing the cardiovascular risks potentially associated with low ... Drug Administration (FDA) announced that it will now require ... may increase their risk for heart attacks and strokes. ... 3, 2015, the agency also stated that it was ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Center, has recently received two awards in the ... Choice Awards on February 27, 2015. The company ... and second place in the “Best Registered Massage ... largest distributed community newspapers in Canada, The Vancouver ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... within the centerfold of The San Francisco Chronicle with ... readership of 500,000 readers. Its digital component is distributed ... a network of top news sites and partner outlets. ... click here. , Milorganite is composed of ...
Breaking Medicine News(10 mins):Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2
... Johnson Institute has transferred key programs and products ... under an agreement reached last week by the ... transfer ensures a continuation of the Johnson Institute,s ... possibility of recovery from alcoholism and dependence on ...
... March 4 Scanning the CDC website can be ... CDC concedes that over two million patients will acquire ... as 100,000 will die as a result. CDC studies ... risks and add 9 additional days to a hospital ...
... March 4 Fingertip Formulary, the leading provider ... data, introduces one-click access to customized formulary data ... web-based formulary reporting platform, now offers subscribers the ... access. The analytics platform offers eleven comprehensive reports ...
... China, March 4 /PRNewswire-Asia-FirstCall/ -- China Shenghuo,Pharmaceutical ... Shenghuo" or,the "Company"), today announced the expansion ... with the Company,s business outlook, to optimize ... Company expanded the number,of senior management personnel ...
... The Quantum Group, Inc. (NYSE Amex: ... Organization (HSO), announced today that Quantum subsidiary Renaissance ... a Strategic Alliance Agreement with Pro Med Healthcare ... offer staffing services to the 2,000 healthcare providers ...
... Elsevier,world-leading publisher of scientific, technical and medical information,products ... 2009 launch of a new,peer-reviewed medical journal in ... (ACOFP), Osteopathic Family Physician. , ... American College of,Osteopathic Family Physicians, is designed to ...
Cached Medicine News:Health News:Johnson Institute Transfers Key Programs and Products to Hazelden Foundation 2Health News:Mercy Hospital at Folsom Acquires Advanced Germicidal Technology to Battle MRSA, C. diff, Acinetobacter and Other Drug-Resistant Pathogens 2Health News:Fingertip Formulary Analytics(R) Offers One-Click Access to Customized Formulary Data and Co-Pay Reports 2Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 2Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 3Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 4Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 2Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 3Health News:Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers 4Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 2Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 3
The Buffered Wright Stain is a single solution stain that contains the fixative, buffer, and stain for rapid and convenient staining of blood smears. It is packaged in a 32-oz. bottle for ease of use...
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....
Albumin (BCG). Storage temp: 15 -30 C. Linearity: 0.5 - 6.0 g/dl. Expected values: 3.5 - 5.5 g/dl. Available with calibrator. Performs 500 number of tests....
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
Medicine Products: